![Frontiers | Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial Frontiers | Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial](https://www.frontiersin.org/files/Articles/811687/fonc-12-811687-HTML/image_m/fonc-12-811687-g001.jpg)
Frontiers | Anlotinib for Recurrent or Metastatic Primary Malignant Bone Tumor: A Multicenter, Single-Arm Trial
![Frontiers | Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy Frontiers | Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy](https://www.frontiersin.org/files/Articles/563653/fimmu-11-563653-HTML-r2/image_m/fimmu-11-563653-g001.jpg)
Frontiers | Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy
![Insertion of Molecular Oxygen into a Palladium−Hydride Bond: Computational Evidence for Two Nearly Isoenergetic Pathways | Journal of the American Chemical Society Insertion of Molecular Oxygen into a Palladium−Hydride Bond: Computational Evidence for Two Nearly Isoenergetic Pathways | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/ja069037v/asset/images/large/ja069037vn00001.jpeg)
Insertion of Molecular Oxygen into a Palladium−Hydride Bond: Computational Evidence for Two Nearly Isoenergetic Pathways | Journal of the American Chemical Society
Development of a New Ternary Al2O3–HAP–Pd Catalyst for Diethyl Ether and Ethylene Production Using the Preferential Dehydration of Ethanol | ACS Omega
![IJMS | Free Full-Text | What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1 IJMS | Free Full-Text | What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1](https://www.mdpi.com/ijms/ijms-22-12314/article_deploy/html/images/ijms-22-12314-g001.png)